$SLS Swinging this one. Chart looks good, bouncing off bottom trend. Management is presenting at Biotech Showcase today could finally have FDA guidance for NPS. Tutes bought $6.5 mill in Direct Offering last week $ONTX In this one for a longer swing. Low risk imo, multiple offerings recently and now has enough cash for 2020. Delisting Notification was recieved in December so theres plenty of time to regain Compliance. Also expecting topline data for Phase 3 in 1H 2020. PT on this is .70s with no news and possibly fill the 1.40 gap with Positive Phase 3 news $TCON Nice chart and undervalued. Has $4/share in cash, cash runway into Q4 2020. Has potential for JNJ to reacquire TRC253 for $45MILL+ and also Phase 2 data in 1H 2020 $DFFN Daily chart looks good imo 5ma cross over 50ma. I think .70 is possible for this one.